sb 203580 has been researched along with Cerebral Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, PH; Endo, H; Kamada, H; Myer, DJ; Niizuma, K; Nito, C | 1 |
1 other study(ies) available for sb 203580 and Cerebral Infarction
| Article | Year |
|---|---|
Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion.
Topics: Animals; Animals, Genetically Modified; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Cerebral Infarction; Cyclooxygenase 2; Enzyme Inhibitors; Humans; Imidazoles; Male; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phospholipases A2, Cytosolic; Phosphorylation; Pyridines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Superoxide Dismutase; Superoxide Dismutase-1; Superoxides | 2008 |